Matauro LLC Buys Shares of 70,314 Oscar Health, Inc. $OSCR

Key Points

• Matauro LLC acquired 70,314 shares of Oscar Health, Inc., valued at approximately $1.5 million, during the second quarter.
• The stock of Oscar Health is currently trading at $19.31 with a market capitalization of $4.99 billion, while institutional investors hold around 75.70% of its shares.
• Despite a 29% year-over-year revenue increase, Oscar Health reported a loss of ($0.89) earnings per share, slightly better than analysts' expectations of ($0.90).

Matauro LLC bought a new stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 70,314 shares of the company's stock, valued at approximately $1,508,000.

Several other institutional investors have also recently made changes to their positions in OSCR. Nuveen LLC bought a new position in shares of Oscar Health in the first quarter worth $29,684,000. Thrive Capital Management LLC boosted its holdings in shares of Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the period. Vanguard Group Inc. boosted its holdings in shares of Oscar Health by 3.7% during the first quarter. Vanguard Group Inc. now owns 19,698,442 shares of the company's stock worth $258,247,000 after purchasing an additional 700,469 shares during the period. American Century Companies Inc. boosted its holdings in shares of Oscar Health by 50.0% during the first quarter. American Century Companies Inc. now owns 1,927,261 shares of the company's stock worth $25,266,000 after purchasing an additional 642,057 shares during the period. Finally, Assenagon Asset Management S.A. lifted its holdings in Oscar Health by 3,878.8% in the second quarter. Assenagon Asset Management S.A. now owns 599,488 shares of the company's stock worth $12,853,000 after buying an additional 584,421 shares during the period. Institutional investors own 75.70% of the company's stock.

Oscar Health Stock Up 2.2%

Shares of NYSE OSCR opened at $19.31 on Friday. The firm's 50-day moving average price is $16.91 and its 200-day moving average price is $15.52. The company has a current ratio of 0.86, a quick ratio of 0.86 and a debt-to-equity ratio of 0.26. The stock has a market capitalization of $4.99 billion, a price-to-earnings ratio of -23.84 and a beta of 1.89. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $22.78.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, topping analysts' consensus estimates of ($0.90) by $0.01. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The company had revenue of $2.86 billion for the quarter, compared to analyst estimates of $2.88 billion. During the same period in the prior year, the company posted $0.20 EPS. The firm's revenue for the quarter was up 29.0% on a year-over-year basis. On average, equities research analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. Baird R W lowered shares of Oscar Health from a "strong-buy" rating to a "hold" rating in a report on Friday, July 25th. Robert W. Baird reaffirmed a "neutral" rating and issued a $14.00 target price (down previously from $28.00) on shares of Oscar Health in a research report on Friday, July 25th. Wall Street Zen downgraded shares of Oscar Health from a "hold" rating to a "sell" rating in a research report on Saturday, August 9th. UBS Group reissued a "sell" rating and set a $11.00 price objective (down previously from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Finally, Barclays cut their price objective on shares of Oscar Health from $17.00 to $11.00 and set an "underweight" rating for the company in a research report on Wednesday, July 23rd. Four analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. According to MarketBeat.com, Oscar Health currently has an average rating of "Strong Sell" and a consensus price target of $12.07.

Insiders Place Their Bets

In related news, insider Mario Schlosser sold 395,000 shares of the stock in a transaction dated Monday, September 22nd. The shares were sold at an average price of $18.43, for a total value of $7,279,850.00. Following the sale, the insider directly owned 501,148 shares of the company's stock, valued at $9,236,157.64. This represents a 44.08% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 24.39% of the stock is owned by company insiders.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.